Nephrosclerosis patients without diabetes and low levels of proteinuria may have rapid kidney function decline: Study
Japan: A groundbreaking post hoc analysis of the BRIGHTEN study has shed light on the intricate relationship between proteinuria and rapid kidney function decline in chronic kidney disease (CKD). The findings, published in Diabetes Research and Clinical Practice, challenge conventional wisdom by highlighting the nuanced impact of proteinuria based on the underlying cause of CKD.
The study found a greater risk than initially predicted of rapid kidney function decline in nephrosclerosis without diabetes (NS-DM) patients with low proteinuria levels.
There is no clarity on whether the effect of proteinuria on rapid kidney function decline is equivalent among non-DKD with diabetes (NDKD+DM), diabetic kidney disease (DKD), and nephrosclerosis without diabetes, particularly in patients with advanced chronic kidney disease (CKD). To clarify the same, Tomohito Gohda, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan, and colleagues conducted a post hoc analysis using BRIGHTEN study data to compare the eGFR slope and the rapid kidney function decline prevalence, in addition to kidney and cardiovascular (CV) outcomes, in Japanese CKD patients among these three CKD categories.
The study included 1038 CKD patients who participated in the BRIGHTEN study. A linear mixed-effect model was applied to estimate each disease group's annual glomerular filtration rate (eGFR) decline.
The following were the key findings of the study:
- The prevalence of rapid decliners (rapid kidney function decline, defined as an eGFR loss of > 5 mL/min/1.73 m2/year) in the DKD group (44.6 %) was significantly higher compared with the NDKD+DM (27.9 %) and NS-DM (27.0 %) groups.
- The prevalence of rapid decliners in different urine total protein to creatinine ratio (UPCR) categories (<0.5, 0.5 to < 1.0, 1.0 to < 3.5, and ≥ 3.5 g/g) were equivalent between the DKD and NS-DM groups.
- The prevalence of a UPCR < 1.0 g/g in rapid decliners of the NS-DM group was more than double that in those of the DKD and NDKD+DM groups.
The findings showed that although NS-DM has a better kidney prognosis owing to its low proteinuria level, the kidney prognosis in NS-DM patients with a proteinuria level (0.5–1.0 g/g) may be worse than assumed.
"We propose a new concept that the effect (and weighting) of proteinuria on rapid kidney function decline may be different and greater in NS-DM patients with low proteinuria (0.5–1.0 g/g) levels compared with DKD or NDKD+DM patients with the same proteinuria level," the researchers wrote.
They suggested that even a relatively low proteinuria level of up to 0.5 g/g should be given more aggressive treatment in patients with NS-DM because they are more likely to experience a rapid eGFR decline versus patients with DKD or NDKD+DM.
Reference:
Gohda, T., Murakoshi, M., Suzuki, Y., Kagimura, T., Wada, T., & Narita, I. (2024). Effect of proteinuria on the rapid kidney function decline in chronic kidney disease depends on the underlying disease: A post hoc analysis of the BRIGHTEN study. Diabetes Research and Clinical Practice, 212, 111682. https://doi.org/10.1016/j.diabres.2024.111682
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.